Basel Medical vs Concord Medical Services
BMGL and CCM side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BMGL and CCM compare
Basel Medical grew revenue faster over the last twelve months (45.2% versus 19.9% for Concord Medical Services).
Basel Medical keeps more of each dollar of sales as profit, with a net margin of −4.5% compared with −20.2% at Concord Medical Services.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BMGL | CCM |
|---|---|---|
| Size and price | ||
| Share price | $0.470 | $3.62 |
| Change, 1 year | −97.2% | −24.4% |
| Change, 5 years | – | −85.3% |
| Beta (5Y) | −0.15 | 0.32 |
| Employees | 81 | 610 |
| StockData Score | ||
| Total score | 3 | 3 |
| Valuation score | 0 | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 1 | 1 |
| Health score | 1 (better) | 0 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 45.2% (better) | 19.9% |
| Revenue growth, 5Y average | – | 15.6% |
| Profitability | ||
| Gross margin | – | 5.6% |
| Operating margin | – | −56.8% |
| Net margin | −4.5% (better) | −20.2% |
| FCF margin | −5.4% (better) | −56.1% |
| Return on invested capital | – | −19.3% |
| Financial health | ||
| Interest coverage | – | −1.7× |
| Current ratio | 1.23 (better) | 0.48 |
| Piotroski F-score | 4 | 6 (better) |
| Ownership | ||
| Held by institutions | – | 0.03% |
| Held by insiders | – | 0.83% |
Go deeper
- BMGL stock overview
- BMGL income statement
- BMGL valuation and score
- CCM stock overview
- CCM income statement
- CCM valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.